No Data
Live Stock: First Week Down, Market Pulls Back a Hair After Records
Earnings Preview: AbbVie (ABBV) Q4 Earnings Expected to Decline
Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224
AbbVie (ABBV) Receives a Buy From Morgan Stanley
AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders
Is AbbVie Stock a Buy?